{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:40:19Z","timestamp":1787064019534,"version":"build-2736575974"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background<\/jats:title>\n We aimed to compare the clinical characteristics of patients with systemic sclerosis (SSc) with or without interstitial lung disease (ILD) to identify relationships with the presence of ILD in SSc at a single center in China.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A cross-sectional study was conducted using retrospective data from the Chinese Rheumatology Data Center. Patients diagnosed with SSc at the Second Affiliated Hospital of Nanchang University between 2013 and 2022 were included. Demographic and clinical characteristics were compared between patients with SSc with and without ILD. Logistic regression analyses were performed to explore these associations.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 227 patients with SSc were included (male:female ratio = 1:4.82), of which 121 (53.3%) were accompanied with ILD. SSc patients with ILD had a higher percentage of diffuse cutaneous systemic sclerosis (dcSSc), sclerodactyly, loss of finger pad, muscle involvement, left ventricular diastolic dysfunction (LVDD), and pulmonary hypertension (PAH), elevated Krebs von den Lungen-6 (KL-6), and elevated ferritin than those without ILD, and a higher modified Rodnan skin score (mRSS), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) (all\n P<\/jats:italic>\n &lt; 0.05). Antinuclear antibody (ANA) and anti-scleroderma-70 (anti-Scl-70) positivity was presented frequently in SSc patients with ILD, while SSc patients without ILD were more often anti-centromere antibody (ACA) positive (all\n P<\/jats:italic>\n &lt; 0.05). On the multivariable analysis, muscle involvement [OR 2.551 (95% CI 1.054\u20136.175),\n P<\/jats:italic>\n = 0.038], LVDD [OR 2.360 (95% CI 1.277\u20134.361),\n P<\/jats:italic>\n = 0.006], PAH [OR 9.134 (95% CI 2.335\u201335.730),\n P<\/jats:italic>\n = 0.001], dcSSc [OR 2.859 (95% CI 1.489\u20135.487),\n P<\/jats:italic>\n = 0.002], PLR [OR 1.005 (95% CI 1.001\u20131.008),\n P<\/jats:italic>\n = 0.020], elevated KL-6 [OR 2.033 (95% CI 1.099\u20133.763),\n P<\/jats:italic>\n = 0.024], and anti-Scl-70 [OR 3.101 (95% CI 1.647\u20135.840),\n P<\/jats:italic>\n &lt; 0.001] were statistically significant associations with SSc patients with ILD.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Systemic sclerosis was found mainly in females. Several important differences in clinical and laboratory characteristics have been demonstrated between SSc patients with or without ILD. Muscle involvement, LVDD, PAH, dcSSc, PLR, elevated KL-6, and Anti-Scl-70 antibody may be associated with SSc in patients with ILD.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2022.1061738","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:31:58Z","timestamp":1670286718000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: A cross-sectional study from a single center of the Chinese Rheumatism Data Center"],"prefix":"10.3389","volume":"9","author":[{"given":"Haoguang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/s0889-857x(03)00025-5","article-title":"Interstitial lung disease in scleroderma.","volume":"29","author":"White","year":"2003","journal-title":"Rheum Dis Clin North Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort.","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11739-011-0517-7","article-title":"The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases.","volume":"6","author":"Murdaca","year":"2011","journal-title":"Intern Emerg Med."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01142","article-title":"Cells in fibrosis and fibrotic diseases.","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235856","article-title":"IL-33\/IL-31 axis in immune-mediated and allergic diseases.","volume":"20","author":"Murdaca","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B6","first-page":"1024","article-title":"Vitamin D levels and potential impact in systemic sclerosis.","volume":"29","author":"Vacca","year":"2011","journal-title":"Clin Exp Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084288","article-title":"Vitamin D and microbiota: is there a link with allergies?","volume":"22","author":"Murdaca","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","article-title":"Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.","volume":"80","author":"Hoffmann-Vold","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02026-2019","article-title":"Predictors of progression in systemic sclerosis patients with interstitial lung disease.","volume":"55","author":"Distler","year":"2020","journal-title":"Eur Respir J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3899\/jrheum.160106","article-title":"Ethnic differences in autoantibody diversity and hierarchy: more clues from a US cohort of patients with systemic sclerosis.","volume":"43","author":"Nandiwada","year":"2016","journal-title":"J Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","article-title":"Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.","volume":"30","author":"Krzyszczak","year":"2011","journal-title":"Clin Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10067-012-2145-7","article-title":"Clinical and serological features of systemic sclerosis in a Chinese cohort.","volume":"32","author":"Wang","year":"2013","journal-title":"Clin Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00296-017-3916-x","article-title":"Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.","volume":"38","author":"S\u00e1nchez-Cano","year":"2018","journal-title":"Rheumatol Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11547-018-0894-3","article-title":"Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.","volume":"123","author":"Salaffi","year":"2018","journal-title":"Radiol Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.semarthrit.2010.03.002","article-title":"Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.","volume":"40","author":"Christmann","year":"2010","journal-title":"Semin Arthritis Rheum."},{"key":"B16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the eular scleroderma trials and research group database.","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5301\/jsrd.5000209","article-title":"Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes.","volume":"1","author":"Peoples","year":"2016","journal-title":"J Scleroderma Relat Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis.","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3899\/jrheum.180042","article-title":"Ethnic variations in systemic sclerosis disease manifestations, internal organ involvement, and mortality.","volume":"46","author":"Al-Sheikh","year":"2019","journal-title":"J Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma).","volume":"23","year":"1980","journal-title":"Arthritis Rheum."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative.","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B22","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC.","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.semarthrit.2018.07.008","article-title":"Defining primary systemic sclerosis heart involvement: a scoping literature review.","volume":"48","author":"Ross","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"B25","first-page":"106","article-title":"UK. Scleroderma study group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis.","volume":"34","author":"Lynch","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.berh.2008.01.008","article-title":"Musculoskeletal involvement in systemic sclerosis.","volume":"22","author":"Randone","year":"2008","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/bor.0000000000000592","article-title":"Management of systemic sclerosis-associated interstitial lung disease.","volume":"31","author":"Roofeh","year":"2019","journal-title":"Curr Opin Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102494","article-title":"Gender-related differences in systemic sclerosis.","volume":"19","author":"Hughes","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1756-185x.14261","article-title":"Clinical features and prognostic factors of systemic sclerosis in Guangxi, China: retrospective, single-center study of long-term survival in 470 patients.","volume":"25","author":"Chen","year":"2022","journal-title":"Int J Rheum Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1007\/s10067-021-05804-6","article-title":"Prevalence and risk factors for left ventricular diastolic dysfunction in systemic sclerosis: a multi-center study of CRDC cohort in China.","volume":"40","author":"Hui","year":"2021","journal-title":"Clin Rheumatol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-022-01242-0","article-title":"Systemic sclerosis patients with negative antinuclear antibodies have distinctive clinical manifestations: a multicenter CRDC cohort in China.","author":"Hui","year":"2022","journal-title":"Z Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1735-4","article-title":"Prognostic profile of systemic sclerosis: analysis of the clinical Eustar cohort in China.","volume":"20","author":"Hu","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1007\/s10067-018-4291-z","article-title":"Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.","volume":"37","author":"Li","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/acr.20336","article-title":"Associations with digital ulcers in a large cohort of systemic sclerosis: results from the canadian scleroderma research group registry.","volume":"63","author":"Khimdas","year":"2011","journal-title":"Arthritis Care Res."},{"key":"B35","first-page":"104","article-title":"Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.","volume":"34","author":"Meyer","year":"2007","journal-title":"J Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","article-title":"The registry of the german network for systemic scleroderma: frequency of disease subsets and patterns of organ involvement.","volume":"47","author":"Hunzelmann","year":"2008","journal-title":"Rheumatology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.semarthrit.2011.10.004","article-title":"Registry of the spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.","volume":"41","author":"Sime\u00f3n-Aznar","year":"2012","journal-title":"Semin Arthritis Rheum."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3899\/jrheum.120283","article-title":"The belgian systemic sclerosis cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.","volume":"39","author":"Vanthuyne","year":"2012","journal-title":"J Rheumatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3899\/jrheum.100298","article-title":"Predictors of survival and causes of death in Japanese patients with systemic sclerosis.","volume":"38","author":"Hashimoto","year":"2011","journal-title":"J Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","article-title":"South Australian scleroderma register: autoantibodies as predictive biomarkers of phenotype and outcome.","volume":"15","author":"Graf","year":"2012","journal-title":"Int J Rheum Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3899\/jrheum.111582","article-title":"Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.","volume":"39","author":"Sampaio-Barros","year":"2012","journal-title":"J Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3899\/jrheum.171443","article-title":"Clinical and laboratory characteristics and mortality in Korean patients with systemic sclerosis: a nationwide multicenter retrospective cohort study.","volume":"45","author":"Moon","year":"2018","journal-title":"J Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002.","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/1756-185x.14206","article-title":"Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: a systematic review and meta-analysis.","volume":"24","author":"Qiu","year":"2021","journal-title":"Int J Rheum Dis."},{"key":"B45","first-page":"1563","article-title":"Left ventricular diastolic function in systemic sclerosis.","volume":"28","author":"Aguglia","year":"2001","journal-title":"J Rheumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2014-205897","article-title":"Digital ulcers predict a worse disease course in patients with systemic sclerosis.","volume":"75","author":"Mihai","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000021734","article-title":"Myopathy is a risk factor for poor prognosis of patients with systemic sclerosis: a retrospective cohort study.","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine."},{"key":"B48","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","article-title":"Disease-related autoantibody profile in patients with systemic sclerosis.","volume":"50","author":"Liaskos","year":"2017","journal-title":"Autoimmunity."},{"key":"B49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5606\/ArchRheumatol.2018.6630","article-title":"Clinical characteristics of systemic sclerosis with interstitial lung disease.","volume":"33","author":"Jung","year":"2018","journal-title":"Arch Rheumatol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0411-1","article-title":"Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.","volume":"16","author":"Akter","year":"2014","journal-title":"Curr Rheumatol Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","article-title":"Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients.","volume":"26","author":"Qin","year":"2016","journal-title":"Mod Rheumatol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092760","article-title":"The relationship between hematological markers of systemic inflammation (neutrophil-to-lymphocyte, platelet-to-lymphocyte, lymphocyte-to-monocyte ratios) and ultrasound disease activity parameters in patients with rheumatoid arthritis.","volume":"9","author":"Targo\u0144ska-St\u0229pniak","year":"2020","journal-title":"J Clin Med."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13992","article-title":"Haematologic indices and disease activity index in primary sjogren\u2019s syndrome.","volume":"75","author":"Y\u0131ld\u0131z","year":"2021","journal-title":"Int J Clin Pract."},{"key":"B54","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/art.40815","article-title":"Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease.","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000018382","article-title":"Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.","volume":"200","author":"Sato","year":"2000","journal-title":"Dermatology."},{"key":"B56","first-page":"429","article-title":"Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis.","volume":"21","author":"Yanaba","year":"2003","journal-title":"Clin Exp Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1061738\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:32:03Z","timestamp":1670286723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1061738\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":56,"alternative-id":["10.3389\/fmed.2022.1061738"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1061738","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"1061738"}}